Featured News
AIM Blog
Fifteen Years of Impact: A Movement Powered by Advocacy
This year marks a milestone in the fight against Alzheimer’s and other dementia: the fifteenth anniversary of the Alzheimer’s Impact Movement (AIM). Since its founding in 2010, I’ve seen AIM become a ...
All News
AIM Blog
State Legislatures Take Action: Supporting Caregivers Through Respite Care
Col. Thomas G. Bowden of Tennessee served for 26 years in the United States Army and commanded more than 900...
AIM Blog
Recognizing AIM’s August Advocate of the Month: Darlene Bradley
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...
Press Release
Senate Passes Bipartisan Bills to Renew Nation’s Commitment to Addressing Alzheimer’s
NAPA Reauthorization Act and Alzheimer’s Accountability and Investment Act Washington, D.C., July 30, 2024 — Today the Senate unanimously passed...
Press Release
Alzheimer’s Association Statement on European Medicines Agency Negative Opinion on Leqembi for the Treatment of Alzheimer’s Disease
CHICAGO, July 26, 2024 — The Alzheimer’s Association is disappointed by today’s decision by the European Medicines Agency (EMA) to...
AIM Blog
Recognizing AIM’s July Advocate of the Month: Molina Gonzales
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...
Press Release
Alzheimer’s Association Welcomes U.S. FDA Approval of Kisunla (Donanemab)
CHICAGO, July 2, 2024 — The Alzheimer’s Association celebrates today’s U.S. Food and Drug Administration (FDA) action to approve Kisunla™...